Table 1 Characterization of the detected nucleoside adducts (A1‒A23), and the 4 unmodified nucleosides, using a HRAM adductomics approach.
From: DNA epigenetic marks are linked to embryo aberrations in amphipods
Detected nucleosides | Molecular ion, m/z [M]+ | Specific fragment, m/z [M-dR]+ | Retention time, min | Identified nucleosides |
|---|---|---|---|---|
A1 | 295.1203 | 179.0739 | 3.51 | |
A2 | 278.1605 | 162.1126 | 3.59 | |
dC | 228.0978 | 112.0507 | 3.81 | 2′-Deoxycytidine, dCa |
A3 | 242.1146 | 126.0664 | 3.97 | 5-Methyl-2′-deoxycytidine, 5-me-dCa |
A4 | 264.0961 | 148.0484 | 3.97 | Na adduct of 5-me-dCb |
A5 | 244.0932 | 128.0457 | 4.48 | 5-Hydroxy-2′-deoxycytidine, 5-OH-dC |
A6 | 229.0818 | 113.0348 | 5.49 | 2′-Deoxyuridine, dU |
A7 | 289.1758 | 173.1288 | 5.60 | |
A8 | 268.1043 | 152.0569 | 6.41 | 8-Hydroxy-2′-deoxyadenosine, 8-OH-dA |
dA | 252.1094 | 136.0620 | 6.41 | 2′-Deoxyadenosine, dAa |
A9 | 239.1139 | 123.0667 | 6.41 | |
A10 | 274.0915 | 158.0440 | 6.42 | Na adduct of dAb |
A11 | 284.1358 | 168.0883 | 6.43 | |
A12 | 300.1299 | 184.0832 | 6.43 | |
A13 | 275.0753 | 159.0280 | 7.29 | Na adduct of dIb |
A14 | 253.0931 | 137.0460 | 7.30 | 2′-Deoxyinosine, dI |
dG | 268.1033 | 152.0568 | 7.51 | 2′-Deoxyguanosine, dGa |
A15 | 274.1148 | 158.0676 | 7.51 | Guanidinohydantoin, Gh |
A16 | 290.0852 | 174.0389 | 7.52 | Na adduct of dGb |
A17 | 306.0603 | 190.0129 | 7.61 | |
T | 243.0970 | 127.0504 | 7.99 | Thymidine, Ta |
A18 | 265.0798 | 149.0324 | 7.99 | Na adduct of Tb |
A19 | 327.0504 | 211.0029 | 8.03 | |
A20 | 236.1281 | 120.0809 | 8.48 | |
A21 | 284.0989 | 168.0518 | 8.75 | 8-Oxo-7, 8-dihydro-2′-deoxyguanosine, 8-oxo-dGa |
A22 | 266.1257 | 150.0777 | 9.42 | N6-Methyl-2′-deoxyadenosine, N6-me-dAa |
A23 | 252.1228 | 136.0759 | 11.34 |